No description
-
2014 (v1)PublicationUploaded on: April 14, 2023
-
2014 (v1)Publication
Health care expenditure devoted to patients with HIV infection has changed considerably during the last decades because of the introduction of Highly Active Anti-Retroviral Therapy (HAART). It is estimated that the largest share of total costs in HIV treatment is attributable to HAART and significant differences in per patient cost are...
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Retrospective multicentre study aiming at analysing the etiology, characteristics and outcome of bloodstream infections (BSI) in people living with HIV (PLWHIV) in an era of modern antiretroviral therapy. Between 2008 and 2015, 79 PLWHIV had at least 1 BSI, for a total of 119 pathogens isolated. Patients were mainly male (72.1%), previous...
Uploaded on: April 14, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023